Skovronsky Daniel is a director of Myriad Genetics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Feb 24 | LLY Lilly(Eli) & Co | Common Stock | Grant | Acquire A | No | No | 737.26 | 12,910 | 9.52 mm | 123,738 |
12 Feb 24 | LLY Lilly(Eli) & Co | RSU Common Stock | Grant | Acquire A | No | No | 0 | 8,989 | 0.00 | 8,989 |
10 Nov 23 | LLY Lilly(Eli) & Co | Common Stock | Gift | Dispose G | No | No | 0 | 17 | 0.00 | 105,321 |
10 Aug 23 | LLY Lilly(Eli) & Co | Common Stock | Gift | Dispose G | No | No | 0 | 249 | 0.00 | 105,338 |
1 Jun 23 | MYGN Myriad Genetics | Common Stock | Grant | Acquire A | No | No | 0 | 15,151 | 0.00 | 70,315 |
10 Feb 23 | LLY Lilly(Eli) & Co | Common Stock | Grant | Acquire A | No | No | 345.12 | 18,388 | 6.35 mm | 105,587 |
10 Feb 23 | LLY Lilly(Eli) & Co | RSU Common Stock | Grant | Acquire A | No | No | 0 | 9,941 | 0.00 | 9,941 |